Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF GASTROENTEROLOGY
Volume 108, Issue 6, Pages 881-891
Publisher
Springer Nature
Online
2013-02-05
DOI
10.1038/ajg.2013.5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2013) David Moher ANNALS OF INTERNAL MEDICINE
- Oral Insulin Secretagogues, Insulin, and Cancer Risk in Type 2 Diabetes Mellitus
- (2012) Chia-Hsuin Chang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Metformin for Liver Cancer Prevention in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
- (2012) Zhi-Jiang Zhang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection
- (2012) Yu-Tse Tsan et al. JOURNAL OF CLINICAL ONCOLOGY
- Statins and Risk Reduction in Hepatocellular Carcinoma: Fact or Fiction?
- (2012) Preet Paul Singh et al. JOURNAL OF CLINICAL ONCOLOGY
- Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial
- (2012) Bernardo Bonanni et al. JOURNAL OF CLINICAL ONCOLOGY
- Functional role of peroxisome-proliferator-activated receptor γ in hepatocellular carcinoma
- (2012) Chung-Wah Wu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
- (2012) György Baffy et al. JOURNAL OF HEPATOLOGY
- Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta-Analysis
- (2012) D. Soranna et al. ONCOLOGIST
- Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
- (2012) Hiroshi Noto et al. PLoS One
- Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC
- (2012) Giovanni Blandino et al. Nature Communications
- Risk of Hepatocellular Carcinoma in Diabetic Patients and Risk Reduction Associated With Anti-Diabetic Therapy: A Population-Based Cohort Study
- (2011) Shih-Wei Lai et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Diabetes, cancer, and metformin: connections of metabolism and cell proliferation
- (2011) Emily Jane Gallagher et al. Annals of the New York Academy of Sciences
- Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
- (2011) Meei-Shyuan Lee et al. BMC CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives: Results from a large population-based follow-up study
- (2011) R. Ruiter et al. DIABETES CARE
- Intensive glucose control and risk of cancer in patients with type 2 diabetes
- (2011) G. Stefansdottir et al. DIABETOLOGIA
- Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States
- (2011) Michael R. Charlton et al. GASTROENTEROLOGY
- Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER-medicare database
- (2011) Tania M. Welzel et al. HEPATOLOGY
- Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus
- (2011) Chia-Hsuin Chang et al. HEPATOLOGY
- Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta-analysis of cohort studies
- (2011) Chenggang Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Impact of Metformin on the Prognosis of Cirrhosis Induced by Viral Hepatitis C in Diabetic Patients
- (2011) Gisèle Nkontchou et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Diabetes and Cancer: A Consensus Report
- (2010) E. Giovannucci et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma
- (2010) Manal M. Hassan et al. CANCER
- Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
- (2010) A. DeCensi et al. Cancer Prevention Research
- Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials
- (2010) J. A. Johnson et al. DIABETOLOGIA
- Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials
- (2010) P. D. Home et al. DIABETOLOGIA
- Glucose-lowering therapies and cancer risk: the trials and tribulations of trials and observations
- (2010) J. A. Johnson et al. DIABETOLOGIA
- Mechanisms by which thiazolidinediones induce anti-cancer effects in cancers in digestive organs
- (2010) Toshikatsu Okumura JOURNAL OF GASTROENTEROLOGY
- Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease
- (2010) Valter Donadon et al. LIVER INTERNATIONAL
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
- (2009) Philip D Home et al. LANCET
- Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection
- (2009) Takumi Kawaguchi et al. LIVER INTERNATIONAL
- Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease
- (2009) Valter Donadon et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth
- (2008) C. Algire et al. ENDOCRINE-RELATED CANCER
- The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
- (2008) I Ben Sahra et al. ONCOGENE
- Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: Potential role of insulin
- (2008) Valter Donadon et al. WORLD JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation